What is Dewey Scientific?
Founded in 2018 and headquartered in Pullman, Washington, Dewey Scientific operates at the intersection of advanced biotechnology and commercial agriculture. The company specializes in providing sophisticated genetic and biotechnological solutions designed to enhance the yield, quality, and resilience of cannabis and hemp crops. By integrating rigorous scientific methodology with practical agricultural applications, Dewey Scientific addresses critical pain points for producers who require high-performance, consistent, and compliant plant materials.
The company's market position is defined by its commitment to data-driven cultivation strategies. As the regulatory environment for hemp and cannabis continues to mature, Dewey Scientific serves as a vital partner for large-scale operations seeking to optimize their biological assets. Their focus on scientific rigor distinguishes them from traditional agricultural suppliers, positioning the firm as a key infrastructure provider in the emerging legal botanical market.
How much funding has Dewey Scientific raised?
Dewey Scientific has raised a total of $4.5M across 2 funding rounds:
Angel/Seed
$1.3M
Series A
$3.2M
Angel/Seed (2019): $1.3M, investors not publicly disclosed
Series A (2021): $3.2M led by Hawthorne Collection Boutique
Key Investors in Dewey Scientific
Hawthorne Collection Boutique
A retail-focused entity that has diversified its portfolio to include strategic investments in emerging biotechnological ventures.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Dewey Scientific?
With the recent influx of capital, Dewey Scientific is expected to prioritize the expansion of its laboratory infrastructure and the acceleration of its genetic research pipeline. The strategic roadmap likely includes scaling its team of specialized scientists and enhancing its proprietary technology platform to support broader commercial adoption. As the company transitions into this next phase of growth, the focus will remain on establishing long-term partnerships with enterprise-level producers who require high-fidelity genetic solutions to maintain a competitive edge in the global market. The firm is poised to leverage its current momentum to solidify its status as a cornerstone of the modern cannabis and hemp biotechnology sector.
See full Dewey Scientific company page
